8-cyclopropyl-4-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one;2-(8-cyclopropyl-5-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde
C70H70N12O10 — CID 161412302
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-cyclopropyl-4-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one;2-(8-cyclopropyl-5-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde
8-cyclopropyl-4-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one;2-(8-cyclopropyl-5-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde (PubChem CID 161412302) has the molecular formula C70H70N12O10 and a molecular weight of 1239.40 g/mol. Its IUPAC name is 8-cyclopropyl-4-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one;2-(8-cyclopropyl-5-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde.
Molecular Properties
| Compound Name | 8-cyclopropyl-4-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one;2-(8-cyclopropyl-5-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde |
|---|---|
| PubChem CID | 161412302 |
| Molecular Formula | C70H70N12O10 |
| Molecular Weight | 1239.40 g/mol |
| Exact Mass | 1238.53 |
| IUPAC Name | 8-cyclopropyl-4-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one;2-(8-cyclopropyl-5-oxo-2,3-dihydro-1H-1,4-benzodiazepin-4-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde |
| SMILES | Cn1cc(-c2cccc(N3CCNc4cc(C5CC5)ccc4C3=O)c2C=O)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(-c2cccc(N3CCNc4cc(C5CC5)ccc4C3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O |
| InChI | InChI=1S/C35H36N6O5.C35H34N6O5/c2*1-39-20-25(18-30(35(39)45)38-32-10-8-24(19-37-32)33(43)40-13-15-46-16-14-40)26-3-2-4-31(28(26)21-42)41-12-11-36-29-17-23(22-5-6-22)7-9-27(29)34(41)44/h2-4,7-10,17-20,22,36,42H,5-6,11-16,21H2,1H3,(H,37,38);2-4,7-10,17-22,36H,5-6,11-16H2,1H3,(H,37,38) |
| InChIKey | VVPZSILBYWMFAZ-UHFFFAOYSA-N |
| XLogP | 8.53 |
| TPSA | 254.90 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 92 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1239.40 |
| LogP ≤ 5 | 8.53 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161412302 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.